NICOLE PAYNE: Open Payments
NPI 1992002190 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 37 payments from 12 companies in 2025. Trend: 2023 $470 · 2024 $961 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $191 |
| United Therapeutics Corporation | 3 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Abbott Laboratories | 3 | $69 |
| Alnylam Pharmaceuticals Inc. | 3 | $65 |
| Novo Nordisk Inc | 3 | $64 |
| BridgeBio Pharma, Inc. | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
Products named: WINREVAIR, ONPATTRO, Tyvaso, Attruby, VERQUVO, Kerendia, CAMZYOS, FARXIGA.
Industry payments across NC — which companies pay providers there.
